Literature DB >> 8682580

Decreased frequency of HLA-DRB1 13 alleles in Frenchwomen with HPV-positive carcinoma of the cervix.

X Sastre-Garau1, M N Loste, A Vincent-Salomon, M Favre, E Mouret, A de la Rochefordiere, J C Durand, E Tartour, V Lepage, D Charron.   

Abstract

Specific types of human papillomaviruses (HPV) are associated with most cases of pre-invasive and invasive neoplasia of the uterine cervix. HLA phenotype influences susceptibility and resistance to viral infections and may therefore influence the course of HPV-associated tumors. Some data suggest that specific HLA class-II alleles may be associated with protection from or susceptibility to papillomavirus-associated lesions, but these results are still controversial. Using molecular probes, we looked for associations between specific DQA1, DQB1, DRB1 HLA class-II alleles, HPV types and cervical cancer. The analysis was performed on a population of 126 patients with invasive cervical cancer. For HLA typing, 165 healthy individuals were taken as controls. The DRB1 1301/02 allele frequency significantly decreased in patients (11%) as compared to controls (29%). This difference in frequency was dependent on the HPV-positive status of tumors and was no longer significant in the group of HPV-negative lesions. The same trends were observed with the DRB1 1301/02-DQA1 0103-DQB1 0603 haplotype frequency. An increase in the frequency of the DRB1 1401/07 and DRB1 03 alleles was observed in patients under 40. Contrary to what has been reported in the literature, no increase in the DRB1 15 allele frequency was observed in our series and only a slight increase in the DQB1 03 frequency was found in patients (70%) compared to controls (58%). In our study, no positive correlations between cervical cancer in Frenchwomen and specific HLA DR-DQ haplotypes has been found. In contrast, a negative correlation between DRB1 1301/ 02 alleles and HPV-positive tumors has been observed. This may suggest a protective effect of DR13 against HPV-associated lesions of the cervix.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8682580     DOI: 10.1002/(SICI)1097-0215(19960621)69:3<159::AID-IJC1>3.0.CO;2-Z

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  11 in total

1.  HLA class II polymorphism: protective or risk factors to breast cancer in Tunisia?

Authors:  Amal Baccar Harrath; Besma Yacoubi Loueslati; Wafa Troudi; Slama Hmida; Syrine Sedkaoui; Amel Dridi; Afef Jridi; Farhat Ben Ayed; Khaled Ben Rhomdhane; Amel Ben Ammar Elgaaied
Journal:  Pathol Oncol Res       Date:  2006-06-24       Impact factor: 3.201

2.  Combination treatment with intralesional cidofovir and viral-DNA vaccination cures large cottontail rabbit papillomavirus-induced papillomas and reduces recurrences.

Authors:  N D Christensen; R Han; N M Cladel; M D Pickel
Journal:  Antimicrob Agents Chemother       Date:  2001-04       Impact factor: 5.191

3.  Inverse modulation of IL-10 and IL-12 in the blood of women with preneoplastic lesions of the uterine cervix.

Authors:  N Jacobs; S L Giannini; J Doyen; A Baptista; M Moutschen; J Boniver; P Delvenne
Journal:  Clin Exp Immunol       Date:  1998-01       Impact factor: 4.330

4.  Possession of HLA class II DRB1*1303 associates with reduced viral loads in chronic HIV-1 clade C and B infection.

Authors:  Boris Julg; Eshia S Moodley; Ying Qi; Danni Ramduth; Shabashini Reddy; Zenele Mncube; Xiaojiang Gao; Philip J Goulder; Roger Detels; Thumbi Ndung'u; Bruce D Walker; Mary Carrington
Journal:  J Infect Dis       Date:  2011-01-21       Impact factor: 5.226

5.  A vigorous virus-specific CD4+ T cell response may contribute to the association of HLA-DR13 with viral clearance in hepatitis B.

Authors:  H M Diepolder; M C Jung; E Keller; W Schraut; J T Gerlach; N Grüner; R Zachoval; R M Hoffmann; C A Schirren; S Scholz; G R Pape
Journal:  Clin Exp Immunol       Date:  1998-08       Impact factor: 4.330

6.  New approach reveals CD28 and IFNG gene interaction in the susceptibility to cervical cancer.

Authors:  Valeska B Guzman; Anatoly Yambartsev; Amador Goncalves-Primo; Ismael D C G Silva; Carmen R N Carvalho; Julisa C L Ribalta; Luiz Ricardo Goulart; Natalia Shulzhenko; Maria Gerbase-Delima; Andrey Morgun
Journal:  Hum Mol Genet       Date:  2008-03-12       Impact factor: 6.150

7.  A comprehensive review on host genetic susceptibility to human papillomavirus infection and progression to cervical cancer.

Authors:  Koushik Chattopadhyay
Journal:  Indian J Hum Genet       Date:  2011-09

8.  Meta-analysis on the relationship between HLA-DRBl gene polymorphism and cervical cancer in Chinese population.

Authors:  Lin-Zhen Wei; Hai-Lin Wang; Xin Liu; Ya-Peng Lu; Fei Xu; Jin-Qiu Yuan; Ya-Qin Ling
Journal:  PLoS One       Date:  2014-02-14       Impact factor: 3.240

9.  Interaction between polymorphisms of the human leukocyte antigen and HPV-16 variants on the risk of invasive cervical cancer.

Authors:  Patricia S de Araujo Souza; Paulo C Maciag; Karina B Ribeiro; Maria Luiza Petzl-Erler; Eduardo L Franco; Luisa L Villa
Journal:  BMC Cancer       Date:  2008-08-22       Impact factor: 4.430

10.  Human Leukocyte Antigen Class I and II Alleles and Cervical Adenocarcinoma.

Authors:  Mahboobeh Safaeian; Lisa G Johnson; Kai Yu; Sophia S Wang; Patti E Gravitt; John A Hansen; Mary Carrington; Stephen M Schwartz; Xiaojiang Gao; Allan Hildesheim; Margaret M Madeleine
Journal:  Front Oncol       Date:  2014-06-19       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.